Ovarian stimulation for assisted reproduction.

Regimens for ovarian stimulation that result in increased circulating follicle-stimulating hormone with low levels of luteinizing hormone produce adequate follicular growth and improved oocyte quality and cycle outcome. Recombinant follicle-stimulating hormone for subcutaneous use and antagonists of gonadotropin-releasing hormone promise to simplify ovarian stimulation in the future.